Correlation Between Reviva Pharmaceuticals and Unicycive Therapeutics

Can any of the company-specific risk be diversified away by investing in both Reviva Pharmaceuticals and Unicycive Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Reviva Pharmaceuticals and Unicycive Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Reviva Pharmaceuticals Holdings and Unicycive Therapeutics, you can compare the effects of market volatilities on Reviva Pharmaceuticals and Unicycive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Reviva Pharmaceuticals with a short position of Unicycive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Reviva Pharmaceuticals and Unicycive Therapeutics.

Diversification Opportunities for Reviva Pharmaceuticals and Unicycive Therapeutics

-0.33

Correlation Coefficient

Reviva Pharmaceuticals  Unicycive Therapeutics

Very good diversification

The 3 months correlation between Reviva and Unicycive is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Reviva Pharmaceuticals Holding and Unicycive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Unicycive Therapeutics and Reviva Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Reviva Pharmaceuticals Holdings are associated (or correlated) with Unicycive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Unicycive Therapeutics has no effect on the direction of Reviva Pharmaceuticals i.e., Reviva Pharmaceuticals and Unicycive Therapeutics go up and down completely randomly.

Pair Corralation between Reviva Pharmaceuticals and Unicycive Therapeutics

Given the investment horizon of 90 days Reviva Pharmaceuticals is expected to generate 4.73 times less return on investment than Unicycive Therapeutics. In addition to that, Reviva Pharmaceuticals is 1.25 times more volatile than Unicycive Therapeutics. It trades about 0.04 of its total potential returns per unit of risk. Unicycive Therapeutics is currently generating about 0.22 per unit of volatility. If you would invest  34.00  in Unicycive Therapeutics on August 30, 2024 and sell it today you would earn a total of  33.80  from holding Unicycive Therapeutics or generate 99.41% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Reviva Pharmaceuticals Holding  vs.  Unicycive Therapeutics

Reviva Pharmaceuticals

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Reviva Pharmaceuticals Holdings are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak basic indicators, Reviva Pharmaceuticals demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Unicycive Therapeutics

Risk-Adjusted Performance

17 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Unicycive Therapeutics are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental indicators, Unicycive Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Reviva Pharmaceuticals and Unicycive Therapeutics

The main advantage of trading using opposite Reviva Pharmaceuticals and Unicycive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Reviva Pharmaceuticals position performs unexpectedly, Unicycive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Unicycive Therapeutics will offset losses from the drop in Unicycive Therapeutics' long position.

The idea behind Reviva Pharmaceuticals Holdings and Unicycive Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.